Merck & Co.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).www.merck.com
1.2k
MENTIONS
626
EPISODES
404
PODCASTS
Search complete. 1150 mentions across 626 episodes found for "Merck & Co.".
Oct 26, 2026
Monday Oct. 26, 2026
B
21:25Bill GundersonHOST
Then Friday is also a very important day with Amazon.
B
21:31Bill GundersonHOST
Intel reporting, Altria, Starbucks, Merck, Lilly, Bristol Myers, MasterCard, Chenier Energy.
B
21:43Bill GundersonHOST
Very important day on Thursday.
B
21:46Bill GundersonHOST
And then on Friday, we're going to get ExxonMobil reporting.
B
25:29Bill GundersonHOST
He makes an interesting comment.
B
25:32Bill GundersonHOST
He says it's more important not what AI does for the Mag 7, but for the other companies.
B
25:41Bill GundersonHOST
493 S&P 500 companies right is it going to help Merck is it going to help Chevron is it going to help Ford is it going to help the rest of us out there will we gain benefits will revenue growth go up will productivity go up he says that so far it's it's delivered a zero payoff outside of tech i was talking to a guy on the trip with the new york giants he works for service now i told him wow that's one of the best stocks i ever found but now it has really really flattened off in recent years it's gone pretty good right now but not like it was in the early days And I asked him what they're doing in that AI space.
B
26:31Bill GundersonHOST
And it's actually quite interesting.
Monday Oct. 26, 2026
B
21:25Bill GundersonHOST
Then Friday is also a very important day with Amazon.
B
21:31Bill GundersonHOST
Intel reporting, Altria, Starbucks, Merck, Lilly, Bristol Myers, MasterCard, Chenier Energy.
B
21:43Bill GundersonHOST
Very important day on Thursday.
B
21:46Bill GundersonHOST
And then on Friday, we're going to get ExxonMobil reporting.
B
25:29Bill GundersonHOST
He makes an interesting comment.
B
25:32Bill GundersonHOST
He says it's more important not what AI does for the Mag 7, but for the other companies.
B
25:41Bill GundersonHOST
493 S&P 500 companies right is it going to help Merck is it going to help Chevron is it going to help Ford is it going to help the rest of us out there will we gain benefits will revenue growth go up will productivity go up he says that so far it's it's delivered a zero payoff outside of tech i was talking to a guy on the trip with the new york giants he works for service now i told him wow that's one of the best stocks i ever found but now it has really really flattened off in recent years it's gone pretty good right now but not like it was in the early days And I asked him what they're doing in that AI space.
B
26:31Bill GundersonHOST
And it's actually quite interesting.
10-22-2026 MetroNews Hotline Presented by Salango Law Hour 2
M
18:51Matt PiperCORRESPONDENT
He sued in December over the broadcaster's misleading edit of a speech he gave to supporters shortly before the January 6th assault on the Capitol.
M
18:59Matt PiperCORRESPONDENT
Shares of Moderna and Merck are falling after reports about the results of the company's widely anticipated personalized melanoma vaccine, suggesting a possible leak of the data that's slated to be released this weekend.
M
19:11Matt PiperCORRESPONDENT
Shares of Moderna plunged as much as 25 percent, while Merck shares dropped 4 percent.
M
19:17Matt PiperCORRESPONDENT
Elsewhere on Wall Street, everything is down.
M
19:19Matt PiperCORRESPONDENT
Matt Piper, Bloomberg Radio.
Market perspectives from experts in the value space
S
32:21speaker_4NARRATOR
Thrivent Large Cap Value Fund's top 10 holdings as of 31 August 2026, excluding derivatives and cash, together accounted for 27.59% of the fund.
S
32:32speaker_4NARRATOR
They are Microsoft Corp., 3.82%, Exxon Mobile Holdings Corp., 3.04%, Amazon.com, Inc., 2.98%, Samsung Electronics Co., Ltd., 2.95%, Bank of America Corp., 2.65%, Merck & Co., Inc., 2.62%, Wells Fargo & Co., 2.56%, Cisco CIST, Inc., 2.52%, Alphabet, Inc., Class C, 2.36%, and Johnson & Johnson, 2.09%.
S
33:10speaker_4NARRATOR
Thrivent MidCap Value ETF's top 10 holdings as of the 31st of August, 2026, excluding derivatives and cash, together accounted for 19.6% of the fund.
S
33:18speaker_4NARRATOR
They are M&T Bancorp, 2.17%, Intercontinental X King, 2.15%, U.S. Bancorp, 2.08%.
Techs Drive Rally ahead of Anthropic IPO
S
1:46Steve BokorHOST
And 15 of the Dow 30 stocks are higher, led by Cisco up 3.5, plus Goldman Sachs and NVIDIA.
S
1:52Steve BokorHOST
Dogs would be Merck and Disney.
S
1:54Steve BokorHOST
Turning to Canada, the TSX up 243 points, 36,031.
S
2:00Steve BokorHOST
We're getting a lift in the mining and gold stocks, no doubt due in part to the election results in British Columbia.
Market Beat | Episode 71
N
1:03Nick EdeHOST
The earnings list is long.
N
1:05Nick EdeHOST
Tech giants Alphabet, Amazon.com, and Microsoft are on deck, along with Visa, Coca-Cola, Boeing, SK Hynix, Eli Lilly, MasterCard, Intel, Merck, Caterpillar, Anheuser-Busch, ExxonMobil, Chevron, AbbVie, AstraZeneca, and Colgate Palmolive.
N
1:22Nick EdeHOST
We are still early in the season, with only 24% of S&P 500 companies reported as of Friday.
N
1:28Nick EdeHOST
Earnings so far are up a big 31% from last quarter, with financial companies the most heavily represented sector.
Mack Paul discusses “Miracle Road: The Story of Research Triangle Park”
M
14:02Mack PaulGUEST
He could see some of these companies starting to locate near universities.
M
14:06Mack PaulGUEST
Merck went to Charlottesville and Virginia.
M
14:08Mack PaulGUEST
So that had an impact on him.
M
14:11Mack PaulGUEST
And he got out a map and looked at North Carolina.
NJ News for 12:00pm, Monday, 10-26-2026
J
1:19Jen UrsulaHOST
Two drug companies say their new cancer treatment cuts the risk of death of melanoma by 42%.
M
1:26Mark MayfieldCORRESPONDENT
Merck and Moderna said on Thursday that a new large trial shows their cancer vaccine called Intesmoron autogene reduces the risk of melanoma death when combined with Merck's immunotherapy medicine, Keytruda.
M
1:39Mark MayfieldCORRESPONDENT
The trial of over 1,000 patients also showed the treatment reduced the spread of the cancer by 38%.
M
1:45Mark MayfieldCORRESPONDENT
Moderna's CEO says the treatment works by creating new T-cells that are specific to your tumor.
Real JB Sports Rd 603 Mon (10-26-26)
J
51:58Josh BertacciniHOST
You know, I remember as a kid being raised by a single mom, my mom, a lot of the time when she would go on business trips, right.
J
52:03Josh BertacciniHOST
She's working in the pharmaceutical industry, Merck, uh, Novartis, those kinds of companies, a couple of different ones.
J
52:09Josh BertacciniHOST
But say she was like going on a trip to, well, I mean, we live near New York.
J
52:12Josh BertacciniHOST
She's going to the city, right? Or she's going to Philly.
1698 Melissa Castiano on Tribal American issues + News & Clips
P
12:36Pete DominickHOST
Speaking of good news, reducing the risk of death or recurrence of melanoma by almost half.
P
12:41Pete DominickHOST
An encouraging signal for treatment seeking federal approval that boosted the fortunes of drug makers Moderna and Merck that usher in a new wave of cancer treatments.
P
12:50Pete DominickHOST
RNA is a miracle.
P
12:52Pete DominickHOST
A miracle.
616 more episodes mention Merck & Co..
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.